Heparan sulfate proteoglycan on leukemic cells is primarily involved in integrin-triggering and its mediated adhesion to endothelial cells.
白血病细胞上的硫酸乙酰肝素蛋白聚糖主要参与整合素触发及其介导的与内皮细胞的粘附。
基本信息
- 批准号:07670550
- 负责人:
- 金额:$ 1.54万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (C)
- 财政年份:1995
- 资助国家:日本
- 起止时间:1995 至 1996
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Leukocyte migration from ciculation into tissue depends on leukocyte integrin-mediated adhesion to endothelium, but integrins cannot function until activated. However, it remains to be understood how tumor cells adhere to endothelium and infiltrate into underlying tissue. We studied mechanisms of extravasation of leukemic cells using adult T cell leukemia (ALT) cells and report the following novel features of cell surface heparan sulfate proteoglycan on ATL cells in ATL cell adhesion to endothelium. (1) ATL cells adhere to endothelial cells through already activated integrins without exogenous stimulation. (2) Different from any other hematopoietic cells, ATL cells express a characteristic heparan sulfate capable of immobilizing heparin-binding chemokine macrophage inflammatory protein (MIP) -1beta, a potent T cell-integrin-trigger, produced by the cells themselves. (3) Competitive interruption of endogenous heparan sulfate proteoglycan-synthesis reduces cell surface MIP-1beta and prev … More ents ATL cells from integrin-mediated adhesion to endothelial cells of ICAM-1 triggered through G-protein. (4) The heparan sulfate proteoglycan on ATL cells characteristically consists of an 100 kDa unknown core protein and extremely weakly sulfated glycosaminoglycan, which has a potency to bind to distinctive heparin-binding cytokines.Thus, we here propose that leukemic cells adhere to endothelial cells through the adhesion cascade, similar to normal leukocyte, and that the cell surface heparan sulfate particularly on ATL cells is pivotally involved in chemokine-dependent autocrine stimulation of integrin-triggering by immobilizing the chemokine on them. This is the first study to explore the significance of interaction among heparan sulfate proteoglycan and heparin-binding cytokine for circulating tumor adhesion. Our finding would warrant further studies that different proteoglycan and cytokine might bring enormous flexibility to the process of leukemic cell infiltration and tumor metastasis and would introduce new pharmacological approaches to control them. Less
白细胞从结缔组织到组织的迁移依赖于白细胞整合素介导的内皮黏附,但整合素只有在被激活后才能发挥作用。然而,肿瘤细胞如何黏附于血管内皮细胞并向其下层组织渗透仍有待进一步了解。我们研究了成人T细胞白血病(ALT)细胞外渗白血病细胞的机制,并报道了ATL细胞表面硫酸乙酰肝素蛋白多糖在ATL细胞与内皮细胞黏附中的以下新特征。(1)ATL细胞通过已激活的整合素与内皮细胞黏附,无需外源性刺激。(2)与任何其他造血细胞不同,ATL细胞表达一种特有的硫酸肝素,能够固定肝素结合的趋化因子巨噬细胞炎性蛋白(MIP)-1β,这是一种由细胞本身产生的强大的T细胞整合素触发器。(3)竞争性阻断内源性硫酸乙酰肝素蛋白多糖合成减少细胞表面mip-1β和前病毒…更多的ATL细胞由整合素介导的与ICAM-1内皮细胞的黏附通过G蛋白触发。(4)ATL细胞表面的硫酸肝素蛋白多糖主要由100 kDa的未知核心蛋白和极弱的硫酸化糖胺多糖组成,具有与不同肝素结合的细胞因子结合的能力。因此,我们认为白血病细胞通过与正常白细胞类似的黏附级联与内皮细胞黏附,细胞表面的硫酸乙酰肝素尤其是ATL细胞表面的硫酸乙酰肝素通过将趋化因子固定在内皮细胞上而参与趋化因子依赖的整合素触发的自分泌刺激。这是首次探讨硫酸肝素蛋白多糖和肝素结合细胞因子之间的相互作用对循环肿瘤黏附的意义。我们的发现将值得进一步研究,即不同的蛋白多糖和细胞因子可能会给白血病细胞侵袭和肿瘤转移过程带来巨大的灵活性,并将引入新的药理学方法来控制它们。较少
项目成果
期刊论文数量(29)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
田中良哉: "サイトカインと接着分子" 臨床病理. 102. 69-77 (1996)
Yoshiya Tanaka:“细胞因子和粘附分子”临床病理学。102. 69-77 (1996)
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Tanaka,Y.: "Osteoblasts are regulated by the cellular adhesion through ICAM-1 and VCAM-1." J. Bone Miner. Res.10巻. 1462-1469 (1995)
Tanaka, Y.:“成骨细胞通过 ICAM-1 和 VCAM-1 进行调节。”J. Bone Miner Res。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Wake,A.: "Calcium-dependent homotypic adhesion through leukocyte function-associated antigen-1/intercellular adhesion molecule-1 induces interleukin-1 and parathyroid hormone-related protein production on adult T-cell leukemia cells in vitro." Blood. 86巻.
Wake, A.:“通过白细胞功能相关抗原 1/细胞间粘附分子 1 进行的钙依赖性同型粘附可在体外诱导成人 T 细胞白血病细胞产生白介素 1 和甲状旁腺激素相关蛋白。”卷。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Koyama, Y., Tanaka, Y., Saito, K., Abe, M., Nakatsuka, K., Morimoto, I., Auron, P.E., Eto, S.: "Cross-linking of intercellular adhesion molecule-1 (CD54) induces AP-1 activation and interleukin-1beta transcription." J.Immunol.157. 5097-5103 (1996)
Koyama, Y.、Tanaka, Y.、Saito, K.、Abe, M.、Nakatsuka, K.、Morimoto, I.、Auron, P.E.、Eto, S.:“细胞间粘附分子 1 的交联(
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Abe,M.: "Regulation of interleukin (IL)-1 β gene transcription induced by IL-1 β in rheumatoid synovial fibroblast-like cells,E11,transformed with simian virus 40 large T antigen" J. Rheumatology. 24(in press). (1997)
Abe,M.:“用猿猴病毒 40 大 T 抗原转化的类风湿滑膜成纤维细胞样细胞 E11 中 IL-1 β 诱导的白细胞介素 (IL)-1 β 基因转录的调节”J. 风湿病学 24(出版中)。 )(1997)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
TANAKA Yoshiya其他文献
TANAKA Yoshiya的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('TANAKA Yoshiya', 18)}}的其他基金
Dynamics of stress-homeosurveillance and its relevance to disease control
应激同源监测的动态及其与疾病控制的相关性
- 批准号:
22249025 - 财政年份:2010
- 资助金额:
$ 1.54万 - 项目类别:
Grant-in-Aid for Scientific Research (A)
Stress-surveillance and signal network originated from dendrite of various cells
源自各种细胞树突的压力监视和信号网络
- 批准号:
18209026 - 财政年份:2006
- 资助金额:
$ 1.54万 - 项目类别:
Grant-in-Aid for Scientific Research (A)
Identification of organ-specific cell surface molecules on T cells and endothelial cells in patients with systemic lupus erythematosus
系统性红斑狼疮患者 T 细胞和内皮细胞上器官特异性细胞表面分子的鉴定
- 批准号:
13470109 - 财政年份:2001
- 资助金额:
$ 1.54万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
The functional heterogeneity of synovial cells in patients with rheumatoid arthritis.
类风湿关节炎患者滑膜细胞的功能异质性。
- 批准号:
11670469 - 财政年份:1999
- 资助金额:
$ 1.54万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Adhesion molecules and soluble factors specifically regulate T lymphocyte function in patients with rheumatoid arthritis.
粘附分子和可溶性因子特异性调节类风湿关节炎患者的 T 淋巴细胞功能。
- 批准号:
05670438 - 财政年份:1993
- 资助金额:
$ 1.54万 - 项目类别:
Grant-in-Aid for General Scientific Research (C)
相似国自然基金
Chemokine-Gli2信号环路调控肝癌生长的分子机制及其靶点价值
- 批准号:81660467
- 批准年份:2016
- 资助金额:39.0 万元
- 项目类别:地区科学基金项目
相似海外基金
Atypical Chemokine Receptors orchestrate changes in vascular patterning during fibrotic liver disease via Endothelial-to-Mesenchymal Transition.
非典型趋化因子受体通过内皮-间质转化协调纤维化肝病期间血管模式的变化。
- 批准号:
MR/Y013751/1 - 财政年份:2024
- 资助金额:
$ 1.54万 - 项目类别:
Research Grant
Potential role of chemokine (C-C motif) ligand 18 in the development of obese asthma and Type 2 inflammation using epidemiological and experimental studies
使用流行病学和实验研究发现趋化因子(C-C 基序)配体 18 在肥胖哮喘和 2 型炎症发展中的潜在作用
- 批准号:
23K09664 - 财政年份:2023
- 资助金额:
$ 1.54万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Knockdown of AdipoR2 Compromises Adiponectin’s Anti-inflammatory Actions by Mainly Promoting a Pro-inflammatory Chemokine and Cytokine Secretory Profile in THP-1 Macrophages
AdipoR2 的敲低主要通过促进 THP-1 巨噬细胞中促炎趋化因子和细胞因子的分泌特征来损害脂联素的抗炎作用
- 批准号:
493138 - 财政年份:2023
- 资助金额:
$ 1.54万 - 项目类别:
Structure-based inhibition of chemokine signaling in the inflamed pancreas
基于结构的炎症胰腺趋化因子信号传导抑制
- 批准号:
10656002 - 财政年份:2023
- 资助金额:
$ 1.54万 - 项目类别:
Targeting Age-Activated Proinflammatory Chemokine Signaling by CCL2/11 to Enhance Skeletal Muscle Regeneration in Aging
通过 CCL2/11 靶向年龄激活的促炎趋化因子信号传导以增强衰老过程中的骨骼肌再生
- 批准号:
478877 - 财政年份:2023
- 资助金额:
$ 1.54万 - 项目类别:
Operating Grants
Mechanism of metastatic control by chemokine receptor ACKR3
趋化因子受体ACKR3控制转移的机制
- 批准号:
23K06639 - 财政年份:2023
- 资助金额:
$ 1.54万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
PET Imaging to Evaluate a Novel Chemokine Antagonist to Protect Synapses in ADRD
PET 成像评估新型趋化因子拮抗剂保护 ADRD 突触
- 批准号:
10818903 - 财政年份:2023
- 资助金额:
$ 1.54万 - 项目类别:
Development of A Dual Chemokine CCL2/CCL5 Neutralizing Single-domainAntibody for Treating Non-alcoholic Steatohepatitis
双趋化因子 CCL2/CCL5 中和单域抗体的开发用于治疗非酒精性脂肪性肝炎
- 批准号:
10761039 - 财政年份:2023
- 资助金额:
$ 1.54万 - 项目类别:
Integrated Imaging Tools for Intercellular Chemokine Signalling
用于细胞间趋化因子信号转导的集成成像工具
- 批准号:
10706896 - 财政年份:2023
- 资助金额:
$ 1.54万 - 项目类别: